SEC ownership of HARROW, INC.

Top holders, 13D/G large-stake signals, insider positions, and transaction flow tied to CIK 0001360214.

Comparable stake leader

Mark L. Baum

Disclosed value leader

Opaleye Management Inc.

Comparable rows

50/50

Latest evidence

31 Mar 2026

Ownership snapshot CIK-linked ownership evidence from parsed SEC filings. 2 signals
Latest 13D/G holder
Mark L. Baum
Latest parsed ownership date
31 Mar 2026
Issuer Names, identifiers, and filing context for this profile. 2 identity fields
Issuer CIK
0001360214
Issuer location
Nashville, TN

Ownership snapshot

Top shareholders of HARROW, INC. (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
Mark L. Baum
Disclosed value leader
Opaleye Management Inc.
Comparable rows
50/50
Latest evidence
31 Mar 2026
13D/G 3/4/5 13F Lead comparable stake: 11% 13D/G row: Mark L. Baum Showing 1-8 of 50 holder rows.

Quick read

Mark L. Baum leads the comparable SEC ownership view at 11%.

50 of 50 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Mark L. Baum's linked filing trail.
Comparable ownership Top 5
Mark L. Baum 11%
Opaleye Management Inc. 7.6%
Daniel Louis Kaufman 5%
BlackRock, Inc. 6.9%
Private Capital Management, LLC 4.2%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-8 of 50 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
Mark L. Baum
13D/G 3/4/5
CHIEF EXECUTIVE OFFICER, Director
11%
$100,085,253
4,056,962 shares
$0 03 Apr 2025
Opaleye Management Inc.
3/4/5 13D/G 13F
10%+ Owner · Company
7.6%
from 13D/G
$146,049,979
3,681,428 shares
-$10,108,067 03 Mar 2026
Daniel Louis Kaufman
13D/G
Daniel Kaufman
5%
$88,491,360
1,878,000 shares
$0 10 Mar 2026
BlackRock, Inc.
13F
Company
13F
6.9%
$90,010,282
2,552,759 shares
31 Mar 2026
Private Capital Management, LLC
13F
Company
13F
4.2%
$55,076,120
1,562,000 shares
31 Mar 2026
VANGUARD CAPITAL MANAGEMENT LLC
13F
Company
13F
3.8%
$49,471,755
1,403,056 shares
31 Mar 2026
Luxor Capital Group, LP
13F
Company
13F
3%
$39,470,044
1,119,400 shares
31 Mar 2026
STATE STREET CORP
13F
Company
13F
2.3%
$30,148,957
855,047 shares
31 Mar 2026
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Forms 3/4/5 flow

Insider trading overview

Net insider flow leans to selling over the last 12 months. Net value: -$9,639,347.

Buys
$468,720
Insiders: 4
Sells
$10,108,067
Insiders: 1
Net
-$9,639,347
Shares: -238,276
Window
Last 12 months
4 rolling buckets
Buy value Sell value
Shares: 15,500 Shares: 253,776
Window (months) Buy shares Sell shares Buy value Sell value Net value
0-3 15,500 0 $468,720 $0 +$468,720
3-6 0 223,572 $0 $9,184,240 -$9,184,240
6-9 0 0 $0 $0 $0
9-12 0 30,204 $0 $923,827 -$923,827

Reporting owners

Insider holders from Forms 3/4/5

Showing 1-16 of 16 reporting-owner rows connected to HARROW, INC.. Open a relationship link for the CIK-to-CIK filing trail.

Rows
16
Largest Forms 3/4/5 holder
Opaleye Management Inc.
Net 12M change
-$9,639,347
Latest report
18 May 2026
Name Relationship Holdings Value Past Year Net Change Change % Valuation Report Date
Opaleye Management Inc. 10%+ Owner $146,049,979 -$10,108,067 -6.5% Filing P/S 03 Mar 2026
Mark L. Baum CHIEF EXECUTIVE OFFICER, Director $90,483,126 +$302,000 +0.33% Filing P/S 14 May 2026
Andrew R. Boll President And Cfo $24,358,902 +$104,650 +0.43% Filing P/S 14 May 2026
John P. Saharek CEO & President, ImprimisRx $10,791,989 Mixed 03 Apr 2025
Richard L. Lindstrom MD Director $1,022,671 Mixed 30 Sep 2022
Martin A. Makary Director $364,950 Mixed 14 Jun 2024
Adrienne L. Graves Director $31,070 +$31,070 +100% Filing P/S 18 May 2026
Lauren P. Silvernail Director $31,000 +$31,000 +100% Filing P/S 18 May 2026
Robert J. Kammer Director Mixed 25 Jun 2021
Teresa Sparks Director Mixed 21 Jun 2023
R. Lawrence van Horn Director Mixed 21 Jun 2023
Francis William Mullery Jr. CEO, ImprimisRx Mixed 06 Oct 2025
Patrick William Sullivan Chief Commercial Officer Mixed 30 Jan 2026
Amir H. Shojaei Chief Scientific Officer Mixed 15 May 2026
Perry J. Sternberg Director Mixed 20 Jun 2025
Randall E. Pollard Chief Accounting Officer Mixed 01 Sep 2025

Recent insider transactions for HARROW, INC.

Showing up to 300 recent insider transactions from the last 12 months.

Insider Symbol Class Transaction % SEC-reported value SEC-reported price Shares Shares owned Date Ownership
Adrienne L. Graves HROW Common Stock Purchase $31,070 $31.07 1,000 1,000 18 May 2026 Direct
Lauren P. Silvernail HROW Common Stock Purchase $31,000 $31.00 1,000 1,000 18 May 2026 Direct
Amir H. Shojaei HROW Restricted Stock Units Award 10,000 10,000 15 May 2026 Direct
Mark L. Baum HROW Common Stock Purchase 0.33% $302,000 $30.20 10,000 2,996,130 14 May 2026 Direct
Andrew R. Boll HROW Common Stock Purchase 0.43% $104,650 $29.90 3,500 814,679 14 May 2026 Direct
Opaleye Management Inc. HROW Common Stock, par value $0.001 per share Sale -6.69% $169,122 $39.67 -4,263 59,428 04 Mar 2026 By Managed Account
Opaleye Management Inc. HROW Common Stock, par value $0.001 per share Sale -3.57% $5,316,061 $39.67 -134,000 3,622,000 04 Mar 2026 By Opaleye, L.P.
Opaleye Management Inc. HROW Common Stock, par value $0.001 per share Sale -2.01% $51,250 $39.15 -1,309 63,691 03 Mar 2026 By Managed Account
Opaleye Management Inc. HROW Common Stock, par value $0.001 per share Sale -1.55% $2,309,992 $39.15 -59,000 3,756,000 03 Mar 2026 By Opaleye, L.P.
Opaleye Management Inc. HROW Common Stock, par value $0.001 per share Sale -7.14% $270,900 $54.18 -5,000 65,000 27 Feb 2026 By Managed Account
Patrick William Sullivan HROW RSU Award 40,000 25,000 30 Jan 2026 Direct
Opaleye Management Inc. HROW Common Stock, par value $0.001 per share Sale -22.2% $1,066,914 $53.35 -20,000 70,000 06 Jan 2026 By Managed Account
Andrew R. Boll HROW Common Stock Tax liability -3.18% -26,665 811,179 12 Dec 2025 Direct
Andrew R. Boll HROW Common Stock Options Exercise 7.71% 60,000 837,844 12 Dec 2025 Direct
Andrew R. Boll HROW Stock Option (Right to Buy) Options Exercise -100% -60,000 0 12 Dec 2025 Direct
Mark L. Baum HROW Common Stock Tax liability -2.61% -79,994 2,986,130 12 Dec 2025 Direct
Mark L. Baum HROW Common Stock Options Exercise 6.24% 180,000 3,066,124 12 Dec 2025 Direct
Mark L. Baum HROW Stock Option (Right to Buy) Options Exercise -100% -180,000 0 12 Dec 2025 Direct
Randall E. Pollard HROW Stock Option (Right to Buy) Award 30,000 30,000 01 Sep 2025 Direct
Mark L. Baum HROW Common stock Tax liability -9.79% -313,338 2,886,124 21 Jul 2025 Direct
Mark L. Baum HROW Common stock Options Exercise 23.1% 600,000 3,199,462 21 Jul 2025 Direct
Andrew R. Boll HROW RSU Award 405,750 405,750 01 Jul 2025 Direct
Mark L. Baum HROW RSU Award 889,500 889,500 01 Jul 2025 Direct
Perry J. Sternberg HROW RSU Award 7,339 7,339 20 Jun 2025 Direct
Lauren P. Silvernail HROW RSU Award 7,339 7,339 20 Jun 2025 Direct
Adrienne L. Graves HROW RSU Award 7,339 7,339 20 Jun 2025 Direct
Opaleye Management Inc. HROW Common Stock, par value $0.001 per share Sale -14.3% $462,033 $30.80 -15,000 90,000 10 Jun 2025 By Managed Account
Opaleye Management Inc. HROW Common Stock, par value $0.001 per share Sale -12.6% $461,794 $30.37 -15,204 105,000 09 Jun 2025 By Managed Account
* marks a reported price that did not pass the local price check.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .